20 January 2017 – Today’s investments in health R&D are poorly aligned with global public health needs. As little as 1% of all funding for health R&D is allocated to diseases such as malaria and tuberculosis, although they account for more than 12% of the global disease burden. The WHO Global Observatory on Health R&D builds on existing data to enable decisions on R&D priorities.
Global Observatory on Health R&D
Извор: Светска здравствена организација - 20.01.2017
